Abiraterona en cáncer de próstata hormono-sensible metastásico

Previous Page

Next Page

Page Background

STAMPEDE: AA+P comparison, patients

James N et al. J Clin Oncol 2017;35(15):LBA5003 (suppl)

STAMPEDE: AA+P comparison, patients

James N et al. J Clin Oncol 2017;35(15):L